...
机译:含有倍转羟基氧化物的慢性疗法不会影响透析患者的熨斗和贫血标志物
Aristotle Univ Thessaloniki Hippokrat Hosp Dept Nephrol Thessaloniki Greece;
Aristotle Univ Thessaloniki Hippokrat Hosp Dept Nephrol Thessaloniki Greece;
Aristotle Univ Thessaloniki Hippokrat Hosp Dept Nephrol Thessaloniki Greece;
Aristotle Univ Thessaloniki Hippokrat Hosp Dept Nephrol Thessaloniki Greece;
Therapeftiki Chron Dialysis Unit Thessaloniki Greece;
424 Mil Hosp Dept Nephrol Thessaloniki Greece;
Aristotle Univ Thessaloniki Hippokrat Hosp Dept Nephrol Thessaloniki Greece;
Aristotle Univ Thessaloniki Hippokrat Hosp Dept Nephrol Thessaloniki Greece;
Aristotle Univ Thessaloniki Hippokrat Hosp Dept Nephrol Thessaloniki Greece;
Dialysis; Phosphate binder; End-stage renal disease; Anemia; Sucroferric oxyhydroxide;
机译:含有倍转羟基氧化物的慢性疗法不会影响透析患者的熨斗和贫血标志物
机译:用羟基氧化物处理的透析患者的铁相关参数
机译:铁基磷酸酯结合剂羟基氧化亚铁对透析患者的长期影响
机译:慢性丙型肝炎患者肝脏染色低HCV RNA水平作为干扰素治疗的预测标志物
机译:口腔健康组分在接受慢性透析治疗的慢性肾病患者中的口腔健康
机译:盐酸羟铁治疗透析患者铁相关参数
机译:用羟基氧化物处理的透析患者的铁相关参数